Dealing with the unexpected: Covid-19 and risk management
This year’s Covid-19 pandemic has highlighted the need for knowledge around dealing with the unexpected. Many will also recall the…
Latest Operations
-
6 months
-
1 year
-
1 year
-
1 year
-
6 months
-
1 year
-
1 year
-
1 year
Worldwide selects ClinSpark eSource platform to automate trials
Worldwide Clinical Trials has implemented Foundry Health’s ClinSpark eSource Platform to automate Phase I first-in-human clinical trials for clinical development.…
Latest News
View MoreWorldwide selects ClinSpark eSource platform to automate trials
Worldwide Clinical Trials has implemented Foundry Health’s ClinSpark eSource Platform to automate Phase I first-in-human clinical trials for clinical development. Phase I trials often face…
Signant Health offers eConsent support for oncology trial in UK
Clinical trial solutions provider Signant Health has agreed to provide electronic informed consent (eConsent) support for an oncology trial by the University of Bristol in…
IQVIA enables direct patient access to trial information
IQVIA has launched a new web-based solution to offer patients a direct access point for clinical trial information following their…
NUCATS secures funds to improve patient participation in US
The $46m funds will be leveraged by NUCATS to speed up clinical and translational discoveries in alliance with Northwestern investigators.…
Athenex announces expansion of clinical research and development
Global biopharmaceutical company Athenex has announced the expansion of its footprint in Europe and Latin America to grow its global…
ACRO in US calls for risk-based monitoring of clinical trials
The Association of Clinical Research Organizations (ACRO) in the US has called for the adoption of risk-based monitoring (RBM) of…
Latest Content
View MoreAthenex announces expansion of clinical research and development
Global biopharmaceutical company Athenex has announced the expansion of its footprint in Europe and Latin America to grow its global…
ACRO in US calls for risk-based monitoring of clinical trials
The Association of Clinical Research Organizations (ACRO) in the US has called for the adoption of risk-based monitoring (RBM) of…
Cabenuva (cabotegravir and rilpivirine) for the Treatment of HIV-1 Infection
Cabenuva is a complete antiretroviral regimen comprising Vocabria (cabotegravir) and Edurant (rilpivirine) for the treatment of HIV-1 infection in adult…
HLA-class-II/Factor VIII (FVIII) Peptidomic Variation in Dendritic Cells
Plasma-derived (pd) or recombinant (r) therapeutic factor VIII proteins (FVIIIs) are infused to arrest/prevent bleeding in patients with hemophilia A…
Nuedexta for the Treatment of Pseudobulbar Affect (PBA)
Nuedexta (dextromethorphan hydrobromide / quinidine sulfate) is a combination drug indicated for the treatment of pseudobulbar affect (PBA). The drug…